Arturo Urrios

Bridging cutting-edge science with high-stakes finance, Arturo leads early-stage initiatives at Ysios Capital. With a PhD in Biomedicine specializing in synthetic biology and an MBA, he previously managed key investments at M Ventures and Wellington Partners. Notably, he was part of the founding team of Seamless Therapeutics, driving the strategy behind its $1.1B collaboration with Lilly. Arturo founded the YVC Collective a European association for life science VC investors, and he remains a pivotal mentor in the European and Singapore biotech ecosystem.